Immunome, Inc. Diluted Shares Outstanding (Weighted Average)
Immunome, Inc. (IMNM) reported Diluted Shares Outstanding (Weighted Average) of 113.27 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-11
- Immunome, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 113.27M shares, a 30.18% increase year-over-year.
- Immunome, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 113.14M shares, a 42.47% increase year-over-year.
- Immunome, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 94.93M shares, a 51.07% increase year-over-year.
- Immunome, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 87.96M shares, a 46.10% increase year-over-year.
- Immunome, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 87.35M shares, a 48.96% increase from fiscal 2024.
- Immunome, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 58.64M shares, a 195.51% increase from fiscal 2023.
- Immunome, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 19.84M shares, a 63.64% increase from fiscal 2022.
- Immunome, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 12.13M shares, a 5.10% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 113.27M shares 10-Q · filed 2026-08-11 | 113.21M shares 10-Q · filed 2026-08-11 | 107.11M shares derived: average of 3 quarters · filed 2026-08-11 | 102.32M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 113.14M shares 10-Q · filed 2026-05-12 | 104.03M shares derived: average of 2 quarters · filed 2026-05-12 | 98.68M shares derived: average of 3 quarters · filed 2026-05-12 | 95.76M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 94.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 91.44M shares derived: average of 2 quarters · filed 2026-03-03 | 89.97M shares derived: average of 3 quarters · filed 2026-08-11 | 87.35M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 87.96M shares 10-Q · filed 2025-11-06 | 87.48M shares derived: average of 2 quarters · filed 2026-08-11 | 84.82M shares 10-Q · filed 2025-11-06 | 79.30M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 87.01M shares 10-Q · filed 2026-08-11 | 83.23M shares 10-Q · filed 2026-08-11 | 76.42M shares derived: average of 3 quarters · filed 2026-08-11 | 72.37M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 79.41M shares 10-Q · filed 2026-05-12 | 71.12M shares derived: average of 2 quarters · filed 2026-05-12 | 67.48M shares derived: average of 3 quarters · filed 2026-05-12 | 65.60M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 62.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 61.52M shares derived: average of 2 quarters · filed 2026-03-03 | 60.99M shares derived: average of 3 quarters · filed 2026-03-03 | 58.64M shares 10-K · filed 2026-03-03 |
| 2024-09-30 | 60.21M shares 10-Q · filed 2025-11-06 | 60.07M shares derived: average of 2 quarters · filed 2025-11-06 | 57.24M shares 10-Q · filed 2025-11-06 | 53.62M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 59.94M shares 10-Q · filed 2025-08-06 | 55.74M shares 10-Q · filed 2025-08-06 | 51.42M shares derived: average of 3 quarters · filed 2025-08-06 | 41.62M shares derived: average of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | 51.54M shares 10-Q · filed 2025-05-12 | 47.17M shares derived: average of 2 quarters · filed 2025-05-12 | 35.51M shares derived: average of 3 quarters · filed 2025-05-12 | 29.68M shares derived: average of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | 42.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 27.50M shares derived: average of 2 quarters · filed 2025-03-19 | 22.40M shares derived: average of 3 quarters · filed 2025-03-19 | 19.84M shares 10-K · filed 2025-03-19 |
| 2023-09-30 | 12.20M shares 10-Q · filed 2024-11-13 | 12.20M shares derived: average of 2 quarters · filed 2024-11-13 | 12.19M shares 10-Q · filed 2024-11-13 | 12.18M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 12.20M shares 10-Q · filed 2024-08-12 | 12.19M shares 10-Q · filed 2024-08-12 | 12.17M shares derived: average of 3 quarters · filed 2024-08-12 | 12.16M shares derived: average of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | 12.18M shares 10-Q · filed 2024-05-14 | 12.16M shares derived: average of 2 quarters · filed 2024-05-14 | 12.15M shares derived: average of 3 quarters · filed 2024-05-14 | 12.14M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 12.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 12.13M shares derived: average of 2 quarters · filed 2024-03-28 | 12.13M shares derived: average of 3 quarters · filed 2024-03-28 | 12.13M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 12.13M shares 10-Q · filed 2023-11-09 | 12.13M shares derived: average of 2 quarters · filed 2023-11-09 | 12.13M shares 10-Q · filed 2023-11-09 | 12.12M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 12.13M shares 10-Q · filed 2023-08-09 | 12.13M shares 10-Q · filed 2023-08-09 | 12.12M shares derived: average of 3 quarters · filed 2023-08-09 | 12.07M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 12.12M shares 10-Q · filed 2023-05-05 | 12.12M shares derived: average of 2 quarters · filed 2023-05-05 | 12.06M shares derived: average of 3 quarters · filed 2023-05-05 | 11.91M shares derived: average of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | 12.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 12.02M shares derived: average of 2 quarters · filed 2023-03-16 | 11.83M shares derived: average of 3 quarters · filed 2023-03-16 | 11.54M shares 10-K · filed 2023-03-16 |
| 2021-09-30 | 11.93M shares 10-Q · filed 2022-11-14 | 11.70M shares derived: average of 2 quarters · filed 2022-11-14 | 11.35M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 11.46M shares 10-Q · filed 2022-08-05 | 11.05M shares 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | 10.64M shares 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | 3.39M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |